BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34799503)

  • 21. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
    Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
    Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
    Lee Y; Bae H; Kim HS
    Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
    Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
    Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases.
    Ondič O; Němcová J; Alaghehbandan R; Černá K; Gomolčáková B; Kinkorová-Luňáčková I; Chytra J; Šidlová H; Hósová M; Bouda J
    Cytopathology; 2020 Jul; 31(4):288-291. PubMed ID: 32289186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Updated Review on Pathology of Endocervical Adenocarcinoma with Emphasis on Clinically Relevant Findings.
    Cimic A; Liu-Jarin X
    Acta Med Acad; 2021 Apr; 50(1):126-135. PubMed ID: 34075768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
    Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
    Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
    Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
    Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
    Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
    Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
    Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
    Rivera-Colón G; Zheng W
    Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor-positive adenocarcinoma of the cervix presenting during pregnancy: Two case reports and review of the literature.
    Wang JCM; Bernard L; Boutross-Tadross O; Mohamed S; Alghamdi S; Salehi A; Sur M; Elit L; Eiriksson LR
    Gynecol Oncol Rep; 2022 Feb; 39():100916. PubMed ID: 35036507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
    Kong CS; Beck AH; Longacre TA
    Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
    Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
    Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Snapshot of the Landscape of Endocervical Adenocarcinoma in Kenya: What Has HPV Got to Do with It?
    Wawire J; Njenga P; Moloo Z; Sung CJ; Quddus MR
    Ann Clin Lab Sci; 2022 Jul; 52(4):621-627. PubMed ID: 36197776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Evolving Spectrum of Precursor Lesions of Cervical Adenocarcinomas.
    Stolnicu S; Talia KL; McCluggage WG
    Adv Anat Pathol; 2020 Sep; 27(5):278-293. PubMed ID: 32482967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
    Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
    Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus messenger RNA expression in adenocarcinoma in situ of the uterine cervix.
    Farnsworth A; Laverty C; Stoler MH
    Int J Gynecol Pathol; 1989; 8(4):321-30. PubMed ID: 2553629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Villoglandular Pattern in HPV-associated Endocervical Adenocarcinoma is Associated With Excellent Prognosis: A Reappraisal of 31 Cases Using IECC and Silva Pattern Classification.
    Stolnicu S; Brito MJ; Karpathiou G; Hoang L; Felix A; Mateoiu C; Fanni D; Reques A; Garcia A; Hardisson D; Talu CK; Furtado A; Abu-Rustum N; Soslow RA; Park KJ
    Int J Gynecol Pathol; 2023 May; 42(3):270-277. PubMed ID: 36508680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.